Skip to Content
Merck
CN
  • Substrate and effector specificity of a guanosine 3':5'-monophosphate phosphodiesterase from rat liver.

Substrate and effector specificity of a guanosine 3':5'-monophosphate phosphodiesterase from rat liver.

The Journal of biological chemistry (1977-08-10)
J Moss, V C Manganiello, M Vaughan
PMID195942
ABSTRACT

Guanosine 3':5'-monophosphate phosphodiesterases, which appear to be under allosteric control, have been partially purified from rat liver supernatant and particulate fractions. The preferred substrate for both phosphodiesterases was cGMP (Km values: cGMP less than cIMP less than cAMP). At subsaturating concentrations of substrate, the phosphodiesterases were stimulated by purine cyclic nucleotides. The order of effectiveness for activation of cyclic nucleotide hydrolysis was cGMP greater than cIMP greater than cAMP greater than cXMP. Using cAMP derivatives as activators of cIMP hydrolysis, modifications in the ribose, cyclic phosphate, and purine moieties were shown to alter the ability of the cyclic nucleotide to activate the supernatant enzyme. cGMP, at concentrations that stimulated cyclic nucleotide hydrolysis, enhanced chymotryptic inactivation of the supernatant phosphodiesterase. At similar concentrations, cAMP was not effective. It appears that on interaction with appropriate cyclic nucleotides, this phosphodiesterase undergoes conformational changes that are associated with increased catalytic activity and enhanced susceptibility to proteolytic attack. Divalent cation may not be required for the nucleotide-phosphodiesterase interaction and resultant change in conformation.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Xanthosine 3′,5′-cyclic monophosphate, ≥98% (HPLC), solid